1.9. Filter solubilized material through a 0.2-pm disposable filter unit. 1.10. Retain 0.5 ml of solubilized material for analysis, use rest for purification (about 45 ml).
Introduction
Gram-negative bacteria synthesize siderophoremediated transport systems for the acquisition of Fe3+, an essential nutrient for growth and metabolism [l] . Iron uptake is initiated by an outermembrane receptor/transporter, which specifically recognizes and binds the iron-ligand complex. Transport across the outer membrane occurs upon interaction between the outer-membrane transporter and an inner-membrane protein comAbbreviation used: FepA, femc enterobactin receptor.
plex, TonB-ExbB-ExbD [2] . Energy derived from the proton-motive force across the inner membrane also appears to be required for transport [3] . TonB-dependent receptors mediate the virulence of pathogenic organisms such as Haemophilus, Neisseria and Yersinia [4, 5] . Several members of the family have also been exploited for antibiotic uptake [6, 7] . To better understand the activetransport mechanism common to all TonB-dependent receptors, we initiated the X-ray structure determination of an Escherichia coli iron receptor/ transporter, ferric enterobactin receptor (FepA) .
FepA is an integral outer-membrane protein which serves as the receptor for ferric enterobactin, a cyclic triester of 2,3-dihydroxybenzoylserine (719 Da). FepA also transports two natural antibiotics, colicins B and D [8] . T h e fepA gene codes for a mature protein of 724 residues (79771 Da), preceded by a 22-residue signal sequence [9] . T h e polypeptide chain is amphipathic, with no stretches of hydrophobic residues of sufficient length to span the outer membrane using a-helices. coli outer membranes [15, 16] , but yields are low (5 mg of purified FepA from 20 litres of cell culture). While the yield of membrane-inserted FepA appears to be limited by the expression host, expression of the mature protein in the absence of its signal sequence leads to deposition of cytoplasmic inclusion bodies in large quantities (1 g of protein per litre of cell culture). T h e use of cytoplasmic aggregates as starting material for crystallization requires a procedure for refolding FepA in vitro. This paper describes the (cytoplasm-targeted) overexpression, refolding, purification and characterization of the E. coli FepA.
Production of cytoplasmic inclusion bodies
T h e E. coli strains DH5a and BL21(DE3) were used for cloning and expression, respectively. Using PCR, a DNA fragment coding for the mature FepA protein was amplified from plasmid pBB2 [17] . T h e primers used in the PCR reaction introduced a NdeI site at the 5' end and a Hind111 site 3' of the stop codon. These sites were used to clone the fragment into vector pET17b (Novagen). T h e resulting plasmid, encoding mature FepA plus an N-terminal methionine, was transformed into BL21(DE3) cells.
For large-scale production of FepA, a 100-ml culture was grown to D,,, = 0.6 in Luria-Bertani medium [18] and was used to inoculate 10 litres of medium. Cells were shaken at 37 "C for 15 h without induction. Cells were harvested by centrifugation for 20 min at 5000 g. Cell pellets were washed once with buffer consisting of 1 0 m M Tris/HCl, p H 8.0/1 m M EDTA/lO% glycerol, then frozen in liquid nitrogen and stored at -80 "C.
In vitro folding of FepA isolated from inclusion bodies
Inclusion bodies were isolated by the method of Nagai and Thegersen [19] . All steps were performed at 4°C. Briefly, cells were lysed by the addition of lysozyme and EDTA, followed by one freeze-thaw cycle (-20 "C). Inclusion bodies were collected by differential centrifugation and washed first with the detergents deoxycholic acid and Nonidet P-40, followed by washes with Triton X-100. These steps removed membrane fragments adhering to the inclusion-body pellet. Purified inclusion bodies from 1 litre of cell culture were solubilized in 20ml of urea buffer (7 M urea/ 50 m M Tris/HCl, p H 7.5/1 m M EDTA). T h e solution was centrifuged for 10 min at 20000g, and the supernatant was applied to a DEAESepharose Fast Flow column (Amersham Pharmacia Biotech) equilibrated with urea buffer. T h e protein was eluted with a linear (&SO0 mM) NaCl gradient in urea buffer. T h e fractions eluting at approximately 200mM NaCl were pooled and dialysed overnight against T E buffer (50 m M Tris/HCl, p H 7.5/1 m M EDTA), producing purified, unfolded FepA. Unfolded FepA is completely soluble in aqueous buffer (without detergent) due to its amphipathic polypeptide chain, and only when the protein is folded in its native conformation is detergent required for solubility. A refolding strategy for FepA was developed from methods which had been used to refold various porins unfolded FepA was diluted to a protein concentration of 10 mg/ml with T E buffer and brought to room temperature. An equal volume of 10% Zwittergent-3,14 was added to the protein solution with stirring. A 10 yo stock solution of SDS was added to a final concentration of 1 yo, and the mixture was stirred for 5 min. T h e detergent concentrations added correspond to 500 times the critical micelle concentration for Zwittergent-3,14 and 17 times the critical micelle concentration for SDS. T h e protein/detergent mixture was then applied to a Sephacryl S-300 26/60 gel-filtration column (Amersham Pharmacia Biotech) equilibrated with 100 m M Tris/HCl, p H 8.0/1 M NaC1/0.05 yo Zwittergent-3,14/10 m M EDTA/0.02 yo NaN, (room temperature). T h e column was eluted at 1 ml/min and 2-ml fractions were collected. Peak fractions were analysed for refolded protein by SDS/PAGE, as folded FepA (and other outermembrane proteins) has a faster electrophoretic mobility on polyacrylamide gels than unfolded FepA, and therefore can be distinguished from unfolded material by this technique. This occurs because the foldedp-barrel is stable in S D S sample buffer and can only be completely unfolded by heating at 100 "C [23] . Fractions containing primarily refolded protein were pooled.
Folded FepA was separated from unfolded material by anion-exchange chromatography (Mono-Q 10/10; Pharmacia) in a buffer containing 50 m M Tris/HCl, p H 7.5/1% octyl polyoxyethylene monoether (C,-POE; Bachem)/l m M EDTA, at 4°C. FepA was eluted with a linear (0-500 mM) NaCl gradient at 1 ml/min, and 1-ml fractions were collected. Unfolded FepA eluted at 75 mM NaCl, whereas folded FepA eluted at 150 m M NaCI. Fractions containing folded FepA were pooled and concentrated to 1 mg/ml, then applied to a Sepharose S-300 26/60 column in the same buffer containing 200 m M NaCl and 0.02 % NaN, (also at 4 "C). Fractions containing pure, folded FepA were pooled. For crystallization experiments, the detergent and buffer components were exchanged using a DEAE-Sepharose CL-6B anion-exchange column as described [15] . Current yields range from 5 to 10 mg of purified, refolded FepA per litre of cell culture.
Characterization and crystallization of refolded FepA
Refolded FepA was able to bind ferric enterobactin (data not shown), but ligand binding at the extracellular side of the lipid bilayer may not indicate overall correct folding of the membrane protein. T o further analyse the refolded material, C D spectra were recorded for unfolded, refolded and native (purified from membranes) FepA (Figure 1) . For the unfolded sample, ureasolubilized and purified material was dialysed against phosphate buffer (10 m M sodium phosphate, p H 7.5). T h e refolded and native samples were exchanged into phosphate buffer plus 0.06 yo dodecyldimethylamine oxide. Protein concentrations were determined by the bicinchoninic acid method [24] , yielding values of 2.0, 5.1 and 4.1 p M for unfolded, refolded and native FepA, respectively. C D measurements were conducted on an Aviv model 62DS spectrophotometer (Aviv, NJ, U.S.A.), using a quartz cell with a path length of 0.1 cm. Spectra were recorded from 200 to 300 nm for refolded and native FepA, and from 210 to 260 nm for unfolded FepA. T h e spectrum for unfolded FepA is typical for a polypeptide in extended conformation, and shows no evidence of @-helical or B-sheet contributions to the secondary structure. In contrast, the spectra for refolded and native FepA are almost identical and show features observed for all$ proteins, with minima at 217 and 218 nm, respectively. T h e refolded sample appears to contain a small amount of unfolded material, as seen in the slightly blue-shifted minimum at 217 nm and the depressed maximum at approximately 200 nm.
Fluorescence emission spectra of unfolded, refolded and native FepA were recorded from 300 CD spectra of unfolded, refolded and native FepA A step size of I nm was used, with an integration window of 3 s.
The spectra are the average of two scans and have been background-corrected, converted t o mean elliptic'ky and smoothed by a polynomial fitting function (Aviv). All spectra were recorded at 25 OC. Wavelength (nrn) to 450 nm with an excitation wavelength of 288 nm, on a Photon Technology International (PTI, Canada) spectrofluorimeter (Figure 2 ). Spectra for refolded and native FepA are almost superimposable, with emission maxima at 337 nm, indicating a hydrophobic environment for the tryptophan residues. T h e spectrum for unfolded FepA is red-shifted, with an emission maximum at 343 nm. This indicates a more hydrophilic environment for the tryptophan residues. A redshifted fluorescence emission spectrum has also been observed for unfolded outer-membrane protein A (OmpA), as compared with folded OmpA [25] . T o probe for more subtle conformational differences between refolded and native FepA, refolded FepA was crystallized using conditions optimized for native FepA [ 15, diffract X-rays to 3 A on the same equipment. T h e weaker diffraction of refolded FepA crystals may be due to residual SDS in the crystals or to other differences in the purification procedure. It is likely that the crystals could be improved by refining the refolding and purification procedures. T h e use of refolded protein for crystal-structure determinations is well documented : several structures of P-barrel proteins have been solved from refolded material [26-281. T o date, FepA is the largest membrane protein to be successfully refolded.
Structure of FepA
T h e FepA structure was solved by X-ray diffraction [16] from native FepA crystals [15] . T h e structure of FepA was predicted to closely resemble the known porin structures [ l l ] , which form hollow P-barrels constricted by a single extracellular loop folded into the barrel lumen. T h e crystal structure revealed that FepA is a twodomain protein: a 22-stranded P-barrel encircles a 16.4-kDa globular domain folded into the barrel pore ( Figure 3 ). T h e fold of the polypeptide chain is straightforward. Residues 154-724 fold as antiparallelp-strands with a simple meander topology ; the sheet curves around such that the first strand is hydrogen-bonded to the last strand, closing the barrel. T h e strands vary in length from 9 to 24 residues, and are tilted approximately 45" relative to the barrel axis. T h e strands are connected by long loops (7-37 residues) on the extracellular side of the barrel and by short turns (2) (3) (4) residues) on the periplasmic side. T h e N-terminal 153 residues form a globular domain characterized by a four-
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Fluorescence emission spectra of unfolded, refolded and native FepA Samples were diluted to 2 pM concentration. A step size of 0.5 nm was used wrth an average scan time of 2 slnm. An excitation wavelength of 288 nm was used to selectively excrte tryptophan residues. Spectra were recorded at 25 "C and have been background-comcted. stranded mixed P-sheet with two long loops. T h e globular domain extends through the length of the pore and completely blocks it, making transport of ferric enterobactin impossible in this conformation. T h e position of the iron atom (not shown in Figure 3) indicates that the ferric enterobactinbinding site may be composed of residues from several extracellular loops and also from portions of the two loops of the globular domain. The
TonB box (residues 12-18) is found at the beginning of the N-terminal domain; it protrudes into the periplasm and is easily accessible for interaction with TonB protein. Currently, the transport mechanism is not understood, but it will clearly differ from the mechanism used by porins.
Conclusions
T h e described refolding procedure It has been estimated that two thirds of all pharmaceutical drugs act on GPCRs, which makes these proteins a major research subject in the pharmaceutical industry. Despite enormous efforts, no high-resolution structure of any member of this family has yet been obtained. This lack of information may be for one of several reasons. One is the limited availability of purified receptors which could be used for structural studies. Their natural abundance in tissue is low and expression Abbreviations used CMC, cntical micellar concentration, GPCR G-protein-coupled receptor, GST, glutathione S-transferase, NTA. nrtnlotnacetic acid 'To whom correspondence should be addressed in heterologous systems is often difficult in terms of yield or homogeneity [3] . In addition, even if a suitable protein preparation was available, GPCRs, as membrane proteins in general, may not readily produce crystals diffracting to high resolution. This paper targets the first problem mentioned above, i.e. the production of large amounts of purified protein. We chose Escherichia coli as a host for expression of a fusion protein containing a receptor sequence as well as an N-terminal glutathione S-transferase (GST) moiety and a Cterminal 6-His tag, thus allowing rapid purification. Expression of these constructs results in the formation of inclusion bodies containing misfolded protein. Although this fact is a major drawback which implies that special techniques must be developed to refold the protein to its native state, inclusion bodies also have advantages. For instance, the yield of expressed protein reaches up to 10 yo of the cellular protein, which is at least 100-fold higher than in any other GPCR-expression system. Inclusion-body protein is insoluble in neutral detergents which allows removal of soluble and membrane proteins by centrifugation and thus facilitates protein purification.
